Published May 1995
| public
Journal Article
MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA^(Lys) and premature translation termination
Abstract
We have investigated the pathogenetic mechanism of the mitochondrial tRNA^(Lys) gene mutation (position 8344) associated with MERRF encephalomyopathy in several mitochondrial DMA (mtDNA)−less cell transformants carrying the mutation and in control cells. A decrease of 50−60% in the specific tRNA^(Lys) aminoacylation capacity per cell was found in mutant cells. Furthermore, several lines of evidence reveal that the severe protein synthesis impairment in MERRF mutation−carrying cells is due to premature termination of translation at each or near each lysine codon, with the deficiency of aminoacylated tRNA^(Lys) being the most likely cause of this phenomenon.
Additional Information
© 1995 Nature Publishing Group. Received 14 November 1994; Accepted 13 February 1995. We are grateful to M. Yoneda, S.T. Lai, N. Goran-Larsson and S. Horai, P. Fernandez-Silva, A. Drew, B. Keeley and L. Tefo for their help and contribution to this work. This work was supported by NIH grant GM-11726 to G.A., Muscular Dystrophy Association grant 37826 to G.A. and A. C. and an P.F.P.I. Fellowship from the Spanish Ministry of Education to J.A.E.Additional details
- Eprint ID
- 58591
- DOI
- 10.1038/ng0595-47
- Resolver ID
- CaltechAUTHORS:20150624-150439462
- GM-11726
- NIH
- 37826
- Muscular Dystrophy Association
- Ministerio de Educación y Cultura (Spain)
- Created
-
2015-06-24Created from EPrint's datestamp field
- Updated
-
2021-11-10Created from EPrint's last_modified field